Turning Point Therapeutics Company
Turning Point Therapeutics is a structure-based drug design pharmaceutical company.
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
San Diego, California, United States
Founded Date:
2013
Investor Type:
For Profit
Total Funding:
$720.7M
Technology:
Anti-infective Drugs
Employee Number:
51-100
Estimated Revenue:
$50M to $100M
Investors Number:
11
Industry:
PharmTech